Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Prospective, Low-intervention Clinical Trial to Validate a Mobile Application ("ProRodinki") in Assessing the Risk of Skin Malignancies

NCT05402046 is registered in ClinicalTrials.gov with MelanomaPRO, Russia as lead sponsor.

NCT NCT05402046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Prospective, Low-intervention Clinical Trial to Validate a Mobile Application ("ProRodinki") in Assessing the Risk of Skin Malignancies
Lead sponsor
MelanomaPRO, Russia
Phase
Not applicable
Overall status
Unknown status
Start date
April 23, 2022
Completion date
April 30, 2024
Enrollment
605 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, bowen's disease, melanoma (skin), melanoma in situ, nevus, nevus halo, nevus, pigmented, nevus, spitz, spot pigmented, squamous cell carcinoma